The present invention relates to a novel biarylamide derivative and a pharmaceutical composition or a cosmetic composition comprising the same as an active ingredient. More particularly, the present invention relates to a novel biarylamide derivative, a pharmaceutical composition or a cosmetic composition for preventing or treating a pigmentation disorder caused by an abnormal excess of melanin or a disease caused by melanocyte hyperplasia comprising the same as an active ingredient. The biarylamide derivative of the present invention inhibits melanin production and thus inhibits melanocyte hyperplasia. Therefore, a cosmetic composition comprising the biarylamide is excellent in a whitening effect, and a pharmaceutical composition comprising the biarylamide is effective in the prevention or treatment of pigmentation disorders of skin such as lentigo, melasma, freckle, etc. and malignant melanoma.
本发明涉及一种新型二芳基酰胺衍
生物,以及包含其作为活性成分的制药组合物或化妆品组合物。更具体地,本发明涉及一种新型二芳基酰胺衍
生物,以及包含其作为活性成分的制药组合物或化妆品组合物,用于预防或治疗由于
黑色素异常过多引起的色素沉着障碍或由
黑色素细胞增生引起的疾病。本发明的二芳基酰胺衍
生物抑制
黑色素的生成,从而抑制
黑色素细胞增生。因此,包含该二芳基酰胺的化妆品组合物具有出色的美白效果,包含该二芳基酰胺的制药组合物对皮肤色素沉着障碍如雀斑、黄褐斑等和恶性
黑色素瘤的预防或治疗具有良好的效果。